ABSTRACT
The stringent response is a broadly conserved stress response system that exhibits functional variability across bacterial clades. Here, we characterize the role of the stringent factor Rel in the nontuberculous mycobacterial pathogen, Mycobacterium abscessus (Mab). We found that deletion of rel does not ablate (p)ppGpp synthesis and that rel does not provide a survival advantage in several stress conditions or in antibiotic treatment. Transcriptional data show that RelMab is involved in regulating expression of anabolism and growth genes in the stationary phase. However, it does not activate transcription of stress response or antibiotic resistance genes and actually represses transcription of many antibiotic resistance genes. This work shows that there is an unannotated (p)ppGpp synthetase in Mab.
IMPORTANCE In this study, we examined the functional roles of the stringent factor Rel in Mycobacterium abscessus (Mab). In most species, stringent factors synthesize the alarmone (p)ppGpp, which globally alters transcription to promote growth arrest and survival under stress and in antibiotic treatment. Our work shows that in Mab, an emerging pathogen that is resistant to many antibiotics, the stringent factor Rel is not solely responsible for synthesizing (p)ppGpp. We find that RelMab downregulates many metabolic genes under stress but does not upregulate stress response genes and does not promote antibiotic tolerance. This study implies that there is another critical but unannotated (p)ppGpp synthetase in Mab and suggests that RelMab inhibitors are unlikely to sensitize Mab infections to antibiotic treatment.
KEYWORDS: (p)ppGpp, Mab, Mycobacterium abscessus, RNA-seq, RelA, antibiotic tolerance, ppGpp, pppGpp, stress adaptation, stress response
INTRODUCTION
Bacteria must adjust their physiology to permit survival in fluctuating conditions. The stringent response is a conserved signaling system that promotes survival of many species in stress and antibiotics by altering the transcription of about a quarter of the genome (1–5). In this work, we profile the role of Rel, the sole annotated stringent factor, in the nontuberculous, rapidly growing Mycobacterium abscessus (Mab). Mab is an opportunistic pathogen that lives in the environment and causes skin and respiratory infections that are increasingly prevalent in cystic fibrosis patients (6). Mab infections are difficult to treat due to intrinsic resistance to many antibiotics (7) and high tolerance under stress to almost all antibiotics tested (8, 9). One proposed strategy to help treat such antibiotic-recalcitrant infections is to inhibit regulatory systems, like the stringent response, which promote antibiotic tolerance (10–13).
The conserved aspect of the stringent response is the synthesis, upon stress, of the hyperphosphorylated guanine (p)ppGpp. Once made, (p)ppGpp affects transcription in different ways (14–17) and also directly modulates replication (18, 19), nucleotide metabolism (20–22), ribosome maturation (23, 24), and translation (25–27).
There are a few different protein families that synthesize (p)ppGpp across bacterial clades. The most widely conserved are the Rel/Spo homolog or RSH proteins, which contain, from N terminus to C terminus, a (p)ppGpp hydrolase domain, a (p)ppGpp synthase domain, and regulatory TGS (threonyl-tRNA synthetase/GTPas/SpoT) and ACT (aspartate kinase/chorismate mutase/TyrA) domains (28). Some RSH proteins associate with the ribosome and sense amino acid starvation by detecting when ribosomes have stalled due to an uncharged tRNA being in the A site (29, 30). Some RSH proteins detect other types of stress or nutrient deprivation via other mechanisms (31–34). Many species have only one RSH-type protein, which is competent for both (p)ppGpp hydrolysis and synthesis (28). Many species encode small alarmose synthetase (SAS) and small alarmone hydrolase (SAH) proteins, which contain only (p)ppGpp synthetase and hydrolase domains, respectively (30, 35–38). Because SAS proteins do not have regulatory domains, they are typically controlled transcriptionally (30). There are a few other (p)ppGpp synthesizing domains that have been preliminarily studied. ToxSAS proteins are part of toxin-antitoxin systems and synthesize (p)ppGpp as a toxin; they are found in both phage and bacterial genomes (39). Streptomyces antibioticus has a polynucleotide phosphorylase (PNPase), which can also synthesize (p)ppGpp (40–43).
The physiological outputs of the stringent response vary across species, but there are conserved themes. First, the stringent response generally downregulates genes required for growth, such as ribosome and cell wall synthesis factors, and alters transcription of central metabolism to prioritize survival rather than construction of new cells (2, 3, 17, 44). Stringent inhibition of growth (44–50) indirectly protects against some stresses and antibiotics that interfere with growth factors. In many species, the stringent response upregulates stress response genes such as heat shock proteins, hibernation factors, and stress-specific transcription factors (3, 51, 52) and promotes survival in stress (13). The stringent response also helps many bacteria survive through antibiotic treatment by promoting antibiotic tolerance (12).
The stringent response has been studied in Mycobacterium tuberculosis (Mtb) and Mycobacterium smegmatis (Msmeg). Mtb has one major (p)ppGpp synthetase, RelMtb, which makes (p)ppGpp when respiration is inhibited, in the stationary phase, and in total carbon and nitrogen starvation (46, 53). RelMtb also promotes survival of Mtb during nutrient and oxygen starvation, stationary phase (46), and chronic infection of mice (1) and guinea pigs (54, 55). Importantly, RelMtb also makes Mtb more tolerant to the first-line clinical antibiotic isoniazid during starvation and infection in mice (11). A PNPase enzyme in Mtb, Rv2783, has been shown to have weak (p)ppGpp synthetase activity (56), and the Mtb genome contains another gene with a predicted GTP pyrophosphokinase domain, Rv1366. However, the ΔrelMtb strain does not synthesize measurable (p)ppGpp in starvation conditions (46), so these other potential synthetases are either inactive or not activated under the conditions tested.
Msmeg has an RSH protein, RelMsmeg, which can both synthesize and hydrolyze (p)ppGpp (57–60). Although the ΔrelMsmeg strain showed defects in biofilm formation and stationary-phase viability, it can still synthesize (p)ppGpp (57, 61). The secondary (p)ppGpp synthetase, RelZMsmeg, has an RNaseHII domain in addition to the conserved SAS ppGpp synthetase domain (59) and also synthesizes pGpp (62). Strains missing both synthetases have further biofilm and aggregation defects but can still synthesize some (p)ppGpp (62), indicating that there is a third, uncharacterized synthetase in Msmeg.
In this study, we examined the Δrel strain of Mab. RelMab is an RSH protein. There are no other RSH genes and no SAS genes in the Mab genome. We found that the ΔrelMab strain still makes (p)ppGpp. The ΔrelMab strain does not exhibit survival defects in several stress conditions including antibiotic treatment but has a growth defect relative to wild type. We measured transcriptional changes in ΔrelMab relative to wild type and found that it helps downregulate many metabolic pathways in the stationary phase.
RESULTS
In order to explore the role of relMab, we built a strain of Mab ATCC 19977 with a deletion of the rel gene (MAB_2876), which has the canonical RSH gene structure, including a (p)ppGpp hydrolase domain, a (p)ppGpp synthetase domain, a TGS domain, and an ACT domain. We measured (p)ppGpp in both the wild-type Mab and ΔrelMab strains, in logarithmic phase and carbon starvation (Fig. 1). We found that both the wild-type and ΔrelMab strain produce (p)ppGpp in both the logarithmic phase and starvation, and the amount of ppGpp is increased in both strains in starvation.
FIG 1.

Thin-layer chromatography (TLC) of guanine nucleotides extracted from 32P-labeled M. abscessus strains from logarithmic phase and starvation.
In many species, rel orthologs promote survival during stress conditions, such as stationary phase, acid stress, starvation, or oxidative stress (5, 35, 46, 49, 63, 64). To evaluate the physiological role of rel in Mab, we assayed survival of wild type, ΔrelMab, and complemented strains upon and after transfer to either carbon starvation (Fig. 2A), salt stress (Fig. 2B), oxidative stress (Fig. 2C), or acidic media (Fig. 2D). Treatment with these stressors did not induce measurable differences in growth or survival of ΔrelMab relative to wild type and the complemented strain. Thus, RelMab does not regulate responses to these stresses under the conditions tested or at least not enough to affect growth or survival. We also found that RelMab does not promote survival in the stationary phase (Fig. 3A). Robust survival in the ΔrelMab in all stress conditions is likely aided by the continued synthesis of (p)ppGpp under stress (Fig. 1). Growth curves showed that ΔrelMab had a significant growth defect relative to wild type and complemented strains (Fig. 3B).
FIG 2.

Contribution of relMab to survival in various stresses. (A) CFU of wild-type M. abscessus strain ATCC 19977 (WT), the ΔrelMab strain, and the complemented ΔrelMab L5::relMab strain in Hartman’s du Bont medium with no glycerol and tyloxapol as a detergent. (B) CFU in 7H9 Middlebrook medium with a pH of 4. (C) CFU in Lennox LB with 1 M NaCl. (D) CFU in Hartmans du Bont medium with 5, 25, or 60 mM tert-butyl peroxide after 24 h. Relative CFU is calculated by taking the ratio between each CFU value and the initial CFU value at time zero. All data points are averages from three biological replicates. Error bars represent standard deviation. There are no significant differences in any of these data by a two-tailed Student’s t test.
FIG 3.

Growth and stationary-phase survival of ΔrelMab. (A) CFU in the stationary phase in 7H9 medium. The 2-day time point is 48 h after diluting logarithmic phase cultures to optical density at 600 nm (OD600) = 0.05. (B) CFU during logarithmic phase growth in 7H9 medium. The graph is set at a log2 scale. Doubling times ± 95% confidence interval are as follows: wild type (WT), 2.15 h ± 0.08; ΔrelMab strain, 4.67 h ± 4.26; ΔrelMab L5::relMab, 2.84 ± 1.85. The P values are for the wild type compared to ΔrelMab. are as follows: for t = 4, P = 0.0415; for t = 7, P = 0.00015; for t = 10, P = 0.006; and for t = 12, P = 0.00029. The P values between wild type and the complemented strain were not significant. The P values between strains in the stationary phase were not significant (data not shown). Asterisks represent significance as measured by the two-tailed Student’s t test: *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; NS, P > 0.05.
Because the stringent response is a major activator of antibiotic tolerance and persistence in many species (5, 65, 66), we sought to assess how Rel contributes to antibiotic tolerance in Mab. First, we treated Mab cultures in logarithmic phase with amikacin, clarithromycin, and cefoxitin, which are commonly prescribed to treat Mab infections (67). We found that clarithromycin and cefoxitin alone were ineffective against all of the strains (Fig. 4A). However, amikacin treatment resulted in 10- to 100-fold decreases in the viability of wild-type and complemented strains but had no effect on ΔrelMab.
FIG 4.

Contribution of relMab to survival in antibiotic treatment. Relative CFU of strains treated with either 200 μg/mL of clarithromycin (Clar), 150 μg/mL of amikacin (Amk), or 80 μg/mL of cefoxitin (Fox) for either (A) 48 h in logarithmic phase or (B) 72 h in the stationary phase. Relative CFU were calculated by taking the ratio between the CFU value after treatment and the initial CFU value at time zero. The bars represent the mean of six to nine biological replicates; the individual values are shown by the dots. Error bars represent standard deviation. The logarithmic phase P values were as follows: (Amk150) WT versus ΔrelMab strain, 0.005; WT versus ΔrelMab L5::relMab strain, 0.01; ΔrelMab versus ΔrelMab L5::relMab strain, 0.004. The stationary phase P values were as follows: (AMK150) WT versus ΔrelMab strain, 0.00017; WT versus ΔrelMab L5::relMab strain, 0.0217; ΔrelMab versus ΔrelMab L5::relMab strain, 0.0017. Asterisks represent significance as measured by the two-tailed Student’s t test: *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; NS, P > 0.05.
Antibiotic tolerance increases in the stationary phase in most bacterial species relative to logarithmic phase (5, 68). We repeated the antibiotic survival experiments on cultures in stasis and found that RelMab does not affect tolerance to clarithromycin or cefoxitin (Fig. 4B). Similar to amikacin treatment in growth, RelMab increased susceptibility relative to wild type and the complemented strains in stasis.
A major function of the stringent response in other bacteria is to regulate transcription (4). To determine the effects of RelMab on transcription, we compared the transcriptome of wild type and ΔrelMab in both the logarithmic and stationary phases using RNA-Seq. We found that RelMab represses many more genes than it activates (see File S1 in the supplemental material).
In logarithmic phase (optical density [OD] = 0.5), when ΔrelMab grows more slowly relative to wild type (Fig. 3B), we found 150 genes repressed by relMab in the wild-type strain at least 3-fold, and only 7 genes were activated. The only annotated upregulated genes are an efflux pump (MAB_0677) and a major facilitator superfamily (MFS) transporter (MAB_0069). We found several mce family genes that were repressed by relMab (Table S2). Mce proteins are typically lipid transporters, but they also play roles in host cell entry and immune modulation (69). We also found two antibiotic resistance genes that are repressed by relMab in logarithmic phase (Table 1).
TABLE 1.
Antibiotic resistance genes (under whiB7 regulon)a
| Mab gene annotation | FC-ΔrelMab vs WT Log | FDR-corrected P value ΔrelMab vs WT Log | FC- ΔrelMab vs WT Stat | FDR-corrected P value ΔrelMab vs WT Stat | FC-WT Stat/WT Log | FDR-corrected P value WT Log vs WT Stat | Mab GO molecular function |
|---|---|---|---|---|---|---|---|
| MAB_0163c | +2 | 1.1E−04 | +40 | 5.1E−12 | +2 | 1.7E−311 | Aminoglycoside phosphotransferase |
| MAB_0185c | +1 | 0.3 | +5.4 | 6.4E−03 | −5.4 | 0 | Arabinosyl transferaseb |
| MAB_0186c | +1 | 0.8 | +9.7 | 1.8E−04 | −7.4 | 0 | Arabinosyl transferaseb |
| MAB_1341 | +1 | 0.45 | +34 | 2.3E−11 | −1.3 | 5.5E−13 | Decarboxylaseb |
| MAB_1342 | +1.4 | 0.03 | +14 | 0 | −1 | 0 | Acyl coenzyme A synthetaseb |
| MAB_1395 | +2.7 | 1.3E−04 | +48 | 5.2E−10 | +1 | 7.2E−29 | Transporterb |
| MAB_1396 | +2.5 | 3.7E−06 | +36 | 0 | −1 | 0 | Multidrug MFS transporter |
| MAB_1846 | −1.3 | 0.44 | +28 | 4.2E−06 | −1.4 | 2.9E−265 | ABC transporterb |
| MAB_2273 | +2.3 | 8.8E−12 | +101 | 1.96E−08 | +2.2 | 0 | MFS transporterb |
| MAB_2297 | +1.5 | 0.02 | +99.2 | 7.1E−08 | −2.1 | 0 | Methyltransferase-erm41b |
| MAB_2310 | +1.3 | 0.5 | +5.7 | 0.03 | +3.6 | 1.5E−50 | Multidrug transporter |
| MAB_2355c | +2.2 | 1.5E−08 | +17 | 0 | +2.8 | 0 | ABC transporterb |
| MAB_2396 | +2.1 | 8.2E−03 | +18 | 7.3E−09 | +1.5 | 4.5E−122 | Probably acetyltransferaseb |
| MAB_2640c | +1.2 | 0.122 | +5 | 5.4E−03 | −2.4 | 0 | Mmr (multidrug transport integral membrane protein) |
| MAB_2736c | +1 | 0.6 | +13 | 1.99E−10 | −3.7 | 0 | ABC transporter |
| MAB_2780c | +1.7 | 0.01 | +27 | 1.14E−07 | +3.3 | 0 | MFS transporterb |
| MAB_2807 | −1 | 0.7 | +5 | 4.4E−03 | −4.7 | 0 | MFS transporter |
| MAB_2875 | +5.4 | 9.7E−06 | +38 | 0 | +1.2 | 1.6E−171 | β-Lactamase |
| MAB_2989 | +2 | 5.1E−04 | +6.8 | 2.9E−05 | +2.93 | 1.1E−222 | Chloramphenicol acetyltransferase |
| MAB_3042c | +2.7 | 1.9E−12 | +24 | 0 | +1.82 | 0 | GTpase-Hflxb |
| MAB_3467c | +6 | 2.5E−03 | +21 | 0 | +92 | 0 | Heat shock proteinb |
| MAB_3508c | +1.8 | 0.3 | +31 | 0.08 | +14 | 0.38 | WhiB7 |
| MAB_3762 | +2 | 2.4E−09 | +11 | 2.9E−10 | +7.09 | 4.9E−143 | Membrane proteinb |
| MAB_3869c | −1.3 | 0.158 | +6.7 | 5.4E−03 | −1.67 | 0 | DNA-directed RNA polymeraseb |
| MAB_4294 | +1.8 | 3.1E−03 | +28 | 0 | +1.88 | 0 | Aminotransferaseb |
| MAB_4395 | +2.4 | 0 | +8 | 8.8E−07 | +1.1 | 0 | Aminoglycoside-2′-N-acetyltransferase |
| MAB_4837 | +4.6 | 0 | +26 | 0 | +1.84 | 1.9E−312 | Aminoglycoside phosphotransferase |
FDR, false discovery rate; Log, logarithmic; Mab, Mycobacterium abscessus; Stat, stationary phase; WT, wild type.
Under the whiB7 regulon.
Even though there was no apparent difference in survival between the wild-type and ΔrelMab strains in the stationary phase, we observed significant differences in transcription. We isolated RNA from stationary phase cultures that were shaken for 48 h after being diluted to an optical density of 0.05. We found hundreds of genes that were repressed by relMab in the wild-type strain in the stationary phase, but none that were activated by relMab 3-fold or more. We found many genes in the WhiB7 regulon (Table 1) that are repressed in the stationary phase, although they are mostly unaffected in logarithmic phase. WhiB7 is a transcription factor that activates many antibiotic resistance genes and promotes resistance to many classes of antibiotics in Mab (70). It is notable that these antibiotic resistance genes are repressed by relMab in stasis, which would imply that wild-type Mab would be more susceptible to antibiotics under this condition, which is what we see in amikacin treatment. In the case of clarithromycin and cefoxitin, increased tolerance through downregulation of target expression may counterbalance the repression of the antibiotic resistance genes, resulting in no differences in susceptibility in our assays (Fig. 4).
We also found several cell wall biosynthetic genes that are downregulated by relMab in the stationary phase (Table S2). Downregulation of growth factors is typical in stringent responses across many bacterial species (2, 3, 47, 66, 71). We see that relMab downregulates many central metabolism genes in the stationary phase (Fig. 5; Table S3), which shows that when Rel is present, it contributes to the decrease in central carbon metabolism during stress. However, it is notable that not all the genes in a given pathway are downregulated equally. We hypothesize that this uneven regulation of certain pathways may allow certain metabolites to accumulate and be redirected to other pathways. In a metabolic pathway in which most of the enzymes are downregulated, we expect that the product of a single gene that is not downregulated will accumulate. We note that many of the metabolites we expect to accumulate converge on the NAD synthesis pathway. In addition, none of the genes in the NAD synthesis pathway are downregulated by relMab, which implies that continued metabolism of NAD, which is a critical cofactor in many pathways, may be important in the stationary phase. From our preliminary analysis, it is clear that RelMab helps regulate growth and central metabolism and affects expression of antibiotic resistance genes; however, it does not seem to upregulate specific stress responses under the conditions tested.
FIG 5.
Repression of central metabolic genes by RelMab during stationary phase. Genes in red are downregulated by RelMab at least 3-fold in the stationary phase, P < 0.05. Genes in black are not significantly regulated by RelMab in the stationary phase. See Table S4 for data. TCA, tricarboxylic acid.
DISCUSSION
Mtb, Msmeg, and Mab all have a stringent response, but they have evolved use of different sets of genes to synthesize the same alarmone. The Mab genome encodes only one annotated RSH gene, relMab (MAB_2876), and no homologs of SAS or SAH genes. relMab is homologous to RSH genes in Mtb and Msmeg. We found that the ΔrelMab strain could still produce (p)ppGpp, consistent with the presence of an unannotated (p)ppGpp synthase. Mab does not have a homolog of the SAS-RNaseHII relZ, which has been characterized in Msmeg (57, 59, 62). Despite this, Msmeg and Mab are similar in having significant (p)ppGpp synthesis in the absence of the RSH gene (Fig. 1) (53) and in exhibiting greater survival with some antibiotics (Fig. 4) (61, 68). Mab does have a homolog of the PNPase, which has been shown to be capable of (p)ppGpp synthesis in Mtb (MAB_3106c) (56). MAB_3106c is transcriptionally upgregulated 4-fold in the Δrel strain compared to wild-type in the stationary phase, indicating that the presence of Rel may decrease the need for transcription of this gene. In the wild-type strain, this gene is also upregulated ∼7-fold in the stationary phase compared to the logarithmic phase, indicating that this gene is used in stress. We therefore propose MAB_3106c as a possible additional (p)ppGpp synthase.
Our results show that the stringent factor RelMab does not promote survival during in vitro stress, although it does promote growth during logarithmic phase (Fig. 2 and 3A). Our transcriptomics analyses corroborate these results, as they indicate that RelMab does not upregulate stress response genes but does alter transcription of growth metabolism genes (see Table S2 and File S1 in the supplemental material). It is possible that increases in (p)ppGpp stimulate transcription of stress response genes in Mab, as is seen in other species (3, 52, 72, 73); our experiments did not test this because in our assays, ΔrelMab synthesizes amounts of (p)ppGpp comparable to those of wild type (Fig. 1). The unannotated ppGpp synthase may contribute to stress response signaling. Our transcriptional data show that RelMab is involved in downregulating metabolism for growth arrest (Fig. 5; Fig. S2), even though (p)ppGpp levels are still present in the ΔrelMab strain. There is precedent for metabolic genes being regulated separately from stress response genes in the stringent response. In Escherichia coli, some metabolic genes are repressed at a lower (p)ppGpp level than is required to induce a regulon of stress-response genes (74). (p)ppGpp likely does not directly bind RNAP in mycobacteria as it does in E. coli (75), and it is currently unknown how it exerts its effects on transcription. Further knowledge of the functioning of the mycobacterial stringent response will be required before we can speculate about the mechanism by which (p)ppGpp could differentially affect transcription of metabolic and stress response genes in Mab.
Mab is notorious for having resistance to many clinical antibiotics and expressing many antibiotic resistance genes (70, 76, 77), which is why it is problematic to treat infections in cystic fibrosis patients (78). We observed in our transcriptional data that RelMab downregulated numerous antibiotic resistance genes in the stationary phase (Table 1). In other species, RSH proteins promote antibiotic tolerance (5, 11, 66) and sometimes also increase expression of antibiotic resistance genes (79, 80). Studies are ongoing to find drugs that would inhibit (p)ppGpp synthesis by RSH proteins (11, 13), as such drugs are expected to increase susceptibility to clinically available antibiotics. Our results indicate that RelMab inhibitors, should they become available, are unlikely to help treat Mab infections. Instead, efforts should focus on identifying the other (p)ppGpp synthetase(s) in Mab so that it can be explored as a drug target.
MATERIALS AND METHODS
Construction of strains.
Primers 1233 to 1238 (see Table S3 in the supplemental material) were used to amplify a 502-bp segment upstream of Mab rel, which included the start codon, a 448-bp segment downstream of Mab rel that included the stop codon, and a 788-bp ZeoR cassette. All three segments were stitched together by PCR to form the Δrel::zeoR double-stranded recombineering knockout construct. ΔrelMab was generated through double-stranded recombineering, as previously described (81) (Fig. S1C). Colonies from the transformation of the Δrel::zeoR construct were PCR-checked by using primers 761 and 1424, primers 1235 and 1236, and primers 762 and 1425 (Fig. S1A). To make the complemented strain, the relMab gene was amplified through PCR using primers 1329 to 1330 and inserted into pKK216 (82) with NdeI and HindIII. This new plasmid, pCB1248, was transformed into the ΔrelMab mutant strain in order to create the complementation strain, ΔrelMab L5::relMab, in which relMab expression is driven by a constitutive promoter (BN17, Fig. S1B).
Media and culture conditions.
All M. abscessus ATCC 19977 wild-type and mutant cultures were started in 7H9 (Becton, Dickinson, Franklin Lakes, NJ) medium with 5 g/liter bovine serum albumin, 2 g/liter dextrose, 0.85 g/liter NaCl, 0.003 g/liter catalase, 0.2% glycerol, and 0.05% Tween 80 and shaken overnight at 37°C until cultures entered the logarithmic phase. For starvation and other specific assays, Hartmans de Bont (HdB) minimal medium was made as described previously (83). The cultures were inoculated to an OD600 of 0.05, unless otherwise stated. All CFU time points were plated on Luria-Bertani (LB) agar and placed in a 37°C incubator for 4 days.
Mab (p)ppGpp extraction and detection.
Mab strains were grown until logarithmic phase (OD600 = 0.5) in homemade 7H9 medium. To maximize 32P labeling, 7H9 medium with 1/25 of normal phosphate levels was used (46). Logarithmic phase Mab cells were pelleted and resuspended in 1 mL of low phosphate 7H9, followed by the addition of 32P-labeled orthophosphoric acid to a final concentration of 100 μCi/mL. 32P-labeled cells were then incubated at 37°C and shaken at 200 rpm for 4 h. Following incubation, the cells were pelleted and resuspended with 100 μl of TBST (Tris-buffered saline, pH 8, with 0.05% tyloxapol) and treated with 1 mg/mL of lysozyme on ice for 20 min. Equal volume 2 M formic acid was then added to each sample, followed by a 5-min centrifugation at maximum speed. Supernatant was then collected for each sample and stored in −20°C. For starvation cultures, a second set of logarithmic phase Mab strains (OD600 = 0.5) were washed and resuspended in TBST. 32P-labeled orthophosphoric acid was added, and (p)ppGpp extraction was performed similarly as logarithmic phase cultures. Following extraction, 20 μl of extract from all cultures were spotted on polyethyleneimine (PEI)-cellulose thin-layer chromatography (TLC) plates and developed in 1.5 M potassium monophosphate buffer (pH 3.4). The plates were then air dried and placed on a phosphor screen (Molecular Dynamics) overnight. The phosphor screens were scanned with a Storm 860 scanner (Amersham Biosciences), and the images were analyzed with ImageQuant software (Molecular Dynamics).
ΔrelMab stress assays.
For all stress assays, strains were prepared and grown into logarithmic phase. Unless otherwise stated, cultures for stress assays were done in 24-well plates and shaken at 130 rpm at 37°C. For carbon starvation, the strains were inoculated in 30 mL inkwells in HdB minimal medium with no glycerol and with tyloxapol as a detergent. For acid stress, the strains were inoculated in 7H9 medium (pH 4). For osmotic stress, the strains were inoculated in LB broth medium with 1 M salt (ACS sodium chloride, VWR Chemicals BDH). For oxidative stress, all strains were inoculated in complete HdB minimal medium, which does not contain catalase, and strains were exposed to different concentrations of tert-butyl hydroperoxide (Alfa Aesar). CFU time points were taken upon inoculation and at 1, 3, and 24 h postinoculation.
ΔrelMab growth curve and stationary-phase survival.
Logarithmic-phase cultures of all strains were inoculated to an OD of 0.05 in 30-mL inkwells in 7H9 medium. Cultures were then placed in shaking incubator at 37°C and 130 rpm. CFU time points were then taken throughout a 12-h period. For stationary-phase survival, a second set of cultures were grown into stationary phase up to 48 h. Initial CFU time point was taken at 48 h after dilution of logarithmic phase samples to an OD600 of 0.05, with subsequent time points taken at 5, 6, 7, 8, 9, and 10 days.
Antibiotic assays.
For the logarithmic phase experiments, the strains were kept in logarithmic phase in 7H9 for ∼24 h and diluted to an OD600 of 0.05 and treated with either 150 μg/mL of amikacin, 200 μg/mL clarythromycin, or 80 μg/mL of cefoxitin. These antibiotic concentrations were chosen because they were shown in a previous study to kill Mab in certain conditions (9). CFU were measured upon treatment (t = 0) and 48 h after treatment (t = 48). For the stationary phase, logarithmic-phase cells at an OD600 of 0.05 were shaken for 48 h and then treated as above. CFUs were measured upon treatment and 72 h after treatment.
RNA isolation, library preparation, and data analysis.
RNA from three biological replicates of each strain and condition was isolated as previously described (84) with some modifications. After growth for ∼24 h in either logarithmic or stationary phase, the cells were transferred to 15-mL conical tubes and centrifuged at 4°C for 3 min at 1,467 × g. The cell pellets were immediately resuspended in 750 μL of TRIzol (Invitrogen) and lysed by bead beating. RNA was purified according to protocol with the Zymogen Direct-zol RNA Miniprep Plus (catalog no. 2070). RNA was processed for Illumina sequencing using the TRuSeq Total RNA Library Prep from Illumina, with bacterial rRNA removal probes provided separately by Illumina. Sequencing was performed using Illumina NovaSeq at the North Texas Genome Center at the University of Texas in Arlington.
Between 50 and 300 million pair end reads per library were mapped to the M. abscessus subsp. abscessus strain ATCC 19977 published genome using CLC Genomic Workbench software (Qiagen). To minimize the skewing effect that certain PCR jackpots had on the data, we adjusted the number of reads mapped from each library so that the number of median reads per gene was equivalent within an experiment. In the logarithmic phase samples, the number of median reads per gene was ∼600. In the stationary-phase samples, the median reads per gene was ∼100. After normalization, the reads per kilobase million (RPKM) values were determined for each gene, and the weighted proportion fold change of RPKM between wild type and ΔrelMab for each condition were calculated by CLC Workbench. The Baggerley’s test was used to generate a false discovery rate-corrected P value. We used an arbitrary cutoff 3-fold change with a false discovery rate corrected P ≤ 0.05 to identify significantly differentially regulated genes between wild type and ΔrelMab under each condition. Because the median reads per gene for logarithmic phase samples was six times higher than for stationary-phase samples, we linearly scaled the fold change values when comparing logarithmic to stationary-phase data to normalize for this difference in read depth.
Real-time PCR.
For RNA-seq validation, real-time PCR (RT-PCR) was performed with the Kapa Biosystems Sybr Fast one-step qRT-PCR kit. RNA was extracted in triplicate from each Mab strain as described above. Primers for reverse-transcription (RT) were designed for each gene of interest by using Primer3 (Table S3). Each 20-μl RT reaction mixture contained 10 μl of one-step SYBR green Master Mix, 1 μl of each primer, 4.5 μl of nuclease-free water, 0.5 μl of qScript One-step RT, and 3 μl of RNA. RT-PCR was done by using Bio-Rad CFX Connect real-time system. The relative target levels (fold change) were calculated using the ΔΔCT method (85), with normalization of RNA targets to TetR transcription factor gene (MAB_1638).
ACKNOWLEDGMENTS
This work was funded by a Pilot and Feasibility Award from the Cystic Fibrosis Foundation (to C.C.B.) and by funding from the National Institutes of Health (grants AI1468269 and GM143053 to J.M.B.).
Footnotes
Supplemental material is available online only.
Contributor Information
Cara C. Boutte, Email: cara.boutte@uta.edu.
Michael J. Federle, University of Illinois at Chicago
REFERENCES
- 1.Dahl JL, Kraus CN, Boshoff HIM, Doan B, Foley K, Avarbock D, Kaplan G, Mizrahi V, Rubin H, Barry CE. 2003. The role of RelMtb-mediated adaptation to stationary phase in long-term persistence of Mycobacterium tuberculosis in mice. Proc Natl Acad Sci USA 100:10026–10031. 10.1073/pnas.1631248100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Traxler MF, Summers SM, Nguyen H-T, Zacharia VM, Hightower GA, Smith JT, Conway T. 2008. The global, ppGpp-mediated stringent response to amino acid starvation in Escherichia coli. Mol Microbiol 68:1128–1148. 10.1111/j.1365-2958.2008.06229.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Boutte CC, Crosson S. 2011. The complex logic of stringent response regulation in Caulobacter crescentus: starvation signalling in an oligotrophic environment. Mol Microbiol 80:695–714. 10.1111/j.1365-2958.2011.07602.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Hauryliuk V, Atkinson GC, Murakami KS, Tenson T, Gerdes K. 2015. Recent functional insights into the role of (p)ppGpp in bacterial physiology. Nat Rev Microbiol 13:298–309. 10.1038/nrmicro3448. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Harms A, Fino C, Sørensen MA, Semsey S, Gerdes K. 2017. Prophages and growth dynamics confound experimental results with antibiotic-tolerant persister cells. mBio 8:e01964-17. 10.1128/mBio.01964-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Johansen MD, Herrmann J-L, Kremer L. 2020. Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus. Nat Rev Microbiol 18:392–407. 10.1038/s41579-020-0331-1. [DOI] [PubMed] [Google Scholar]
- 7.Nessar R, Cambau E, Reyrat JM, Murray A, Gicquel B. 2012. Mycobacterium abscessus: a new antibiotic nightmare. J Antimicrob Chemother 67:810–818. 10.1093/jac/dkr578. [DOI] [PubMed] [Google Scholar]
- 8.Clary G, Sasindran SJ, Nesbitt N, Mason L, Cole S, Azad A, McCoy K, Schlesinger LS, Hall-Stoodley L. 2018. Mycobacterium abscessus smooth and rough morphotypes form antimicrobial-tolerant biofilm phenotypes but are killed by acetic acid. Antimicrob Agents Chemother 62:e01782-17. 10.1128/AAC.01782-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Hunt-Serracin AC, Parks BJ, Boll J, Boutte CC. 2019. Mycobacterium abscessus cells have altered antibiotic tolerance and surface glycolipids in artificial cystic fibrosis sputum medium. Antimicrob Agents Chemother 63:e02488-18. 10.1128/AAC.02488-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Wexselblatt E, Oppenheimer-Shaanan Y, Kaspy I, London N, Schueler-Furman O, Yavin E, Glaser G, Katzhendler J, Ben-Yehuda S. 2012. Relacin, a novel antibacterial agent targeting the stringent response. PLoS Pathog 8:e1002925. 10.1371/journal.ppat.1002925. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Dutta NK, Klinkenberg LG, Vazquez M-J, Segura-Carro D, Colmenarejo G, Ramon F, Rodriguez-Miquel B, Mata-Cantero L, Porras-De Francisco E, Chuang Y-M, Rubin H, Lee JJ, Eoh H, Bader JS, Perez-Herran E, Mendoza-Losana A, Karakousis PC. 2019. Inhibiting the stringent response blocks Mycobacterium tuberculosis entry into quiescence and reduces persistence. Sci Adv 5:eaav2104. 10.1126/sciadv.aav2104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Hobbs JK, Boraston AB. 2019. (p)ppGpp and the stringent response: an emerging threat to antibiotic therapy. ACS Infect Dis 5:1505–1517. 10.1021/acsinfecdis.9b00204. [DOI] [PubMed] [Google Scholar]
- 13.Pacios O, Blasco L, Bleriot I, Fernandez-Garcia L, Ambroa A, López M, Bou G, Cantón R, Garcia-Contreras R, Wood TK, Tomás M. 2020. (p)ppGpp and its role in bacterial persistence: new challenges. Antimicrob Agents Chemother 64:e01283-20. 10.1128/AAC.01283-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Barker MM, Gaal T, Josaitis CA, Gourse RL. 2001. Mechanism of regulation of transcription initiation by ppGpp. I. Effects of ppGpp on transcription initiation in vivo and in vitro, Edited by R. Ebright. J Mol Biol 305:673–688. 10.1006/jmbi.2000.4327. [DOI] [PubMed] [Google Scholar]
- 15.Barker MM, Gaal T, Gourse RL. 2001. Mechanism of regulation of transcription initiation by ppGpp. II. Models for positive control based on properties of RNAP mutants and competition for RNAP11Edited by R. Ebright. J Mol Biol 305:689–702. 10.1006/jmbi.2000.4328. [DOI] [PubMed] [Google Scholar]
- 16.Krásný L, Gourse RL. 2004. An alternative strategy for bacterial ribosome synthesis: Bacillus subtilis rRNA transcription regulation. EMBO J 23:4473–4483. 10.1038/sj.emboj.7600423. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Krásný L, Tišerová H, Jonák J, Rejman D, Šanderová H. 2008. The identity of the transcription +1 position is crucial for changes in gene expression in response to amino acid starvation in Bacillus subtilis. Mol Microbiol 69:42–54. 10.1111/j.1365-2958.2008.06256.x. [DOI] [PubMed] [Google Scholar]
- 18.Maciag M, Kochanowska M, Lyzeń R, Wegrzyn G, Szalewska-Pałasz A. 2010. ppGpp inhibits the activity of Escherichia coli DnaG primase. Plasmid 63:61–67. 10.1016/j.plasmid.2009.11.002. [DOI] [PubMed] [Google Scholar]
- 19.Kraemer JA, Sanderlin AG, Laub MT. 2019. The stringent response inhibits DNA replication initiation in E. coli by modulating supercoiling of oriC. mBio 10:e01330-19. 10.1128/mBio.01330-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Kriel A, Bittner AN, Kim SH, Liu K, Tehranchi AK, Zou WY, Rendon S, Chen R, Tu BP, Wang JD. 2012. Direct regulation of GTP homeostasis by (p)ppGpp: a critical component of viability and stress resistance. Mol Cell 48:231–241. 10.1016/j.molcel.2012.08.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Wang B, Dai P, Ding D, Del Rosario A, Grant RA, Pentelute BL, Laub MT. 2019. Affinity-based capture and identification of protein effectors of the growth regulator ppGpp. 2. Nat Chem Biol 15:141–150. 10.1038/s41589-018-0183-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Wang B, Grant RA, Laub MT. 2020. ppGpp coordinates nucleotide and amino-acid synthesis in E. coli during starvation. Mol Cell 80:29–42.e10. S1097276520305487. 10.1016/j.molcel.2020.08.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Fan H, Hahm J, Diggs S, Perry JJP, Blaha G. 2015. Structural and functional analysis of BipA, a regulator of virulence in enteropathogenic Escherichia coli. J Biol Chem 290:20856–20864. 10.1074/jbc.M115.659136. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Corrigan RM, Bellows LE, Wood A, Gründling A. 2016. ppGpp negatively impacts ribosome assembly affecting growth and antimicrobial tolerance in Gram-positive bacteria. Proc Natl Acad Sci USA 113:E1710–E1719. 10.1073/pnas.1522179113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Rojas A-M, Ehrenberg M, Andersson SGE, Kurland CG. 1984. ppGpp inhibition of elongation factors Tu, G and Ts during polypeptide synthesis. Mol Gen Genet 197:36–45. 10.1007/BF00327920. [DOI] [PubMed] [Google Scholar]
- 26.Milon P, Tischenko E, Tomsic J, Caserta E, Folkers G, La Teana A, Rodnina MV, Pon CL, Boelens R, Gualerzi CO. 2006. The nucleotide-binding site of bacterial translation initiation factor 2 (IF2) as a metabolic sensor. Proc Natl Acad Sci USA 103:13962–13967. 10.1073/pnas.0606384103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Mitkevich VA, Ermakov A, Kulikova AA, Tankov S, Shyp V, Soosaar A, Tenson T, Makarov AA, Ehrenberg M, Hauryliuk V. 2010. Thermodynamic characterization of ppGpp binding to EF-G or IF2 and of initiator tRNA binding to free IF2 in the presence of GDP, GTP, or ppGpp. J Mol Biol 402:838–846. 10.1016/j.jmb.2010.08.016. [DOI] [PubMed] [Google Scholar]
- 28.Atkinson GC, Tenson T, Hauryliuk V. 2011. The RelA/SpoT homolog (RSH) superfamily: distribution and functional evolution of ppGpp synthetases and hydrolases across the tree of life. PLoS One 6:e23479. 10.1371/journal.pone.0023479. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Haseltine WA, Block R. 1973. Synthesis of guanosine tetra- and pentaphosphate requires the presence of a codon-specific, uncharged transfer ribonucleic acid in the acceptor site of ribosomes. Proc Natl Acad Sci USA 70:1564–1568. 10.1073/pnas.70.5.1564. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Ronneau S, Hallez R. 2019. Make and break the alarmone: regulation of (p)ppGpp synthetase/hydrolase enzymes in bacteria. FEMS Microbiol Rev 43:389–400. 10.1093/femsre/fuz009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Battesti A, Bouveret E. 2006. Acyl carrier protein/SpoT interaction, the switch linking SpoT-dependent stress response to fatty acid metabolism. Mol Microbiol 62:1048–1063. 10.1111/j.1365-2958.2006.05442.x. [DOI] [PubMed] [Google Scholar]
- 32.Brown DR, Barton G, Pan Z, Buck M, Wigneshweraraj S. 2014. Nitrogen stress response and stringent response are coupled in Escherichia coli. Nat Commun 5:4115. 10.1038/ncomms5115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Ronneau S, Petit K, De Bolle X, Hallez R. 2016. Phosphotransferase-dependent accumulation of (p)ppGpp in response to glutamine deprivation in Caulobacter crescentus. Nat Commun 7:11423. 10.1038/ncomms11423. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Germain E, Guiraud P, Byrne D, Douzi B, Djendli M, Maisonneuve E. 2019. YtfK activates the stringent response by triggering the alarmone synthetase SpoT in Escherichia coli. Nat Commun 10:5763. 10.1038/s41467-019-13764-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Nanamiya H, Kasai K, Nozawa A, Yun C-S, Narisawa T, Murakami K, Natori Y, Kawamura F, Tozawa Y. 2008. Identification and functional analysis of novel (p)ppGpp synthetase genes in Bacillus subtilis: novel (p)ppGpp synthetase genes in B. subtilis. Mol Microbiol 67:291–304. 10.1111/j.1365-2958.2007.06018.x. [DOI] [PubMed] [Google Scholar]
- 36.Ruwe M, Kalinowski J, Persicke M. 2017. Identification and functional characterization of small alarmone synthetases in Corynebacterium glutamicum. Front Microbiol 8:1601. 10.3389/fmicb.2017.01601. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Ruwe M, Rückert C, Kalinowski J, Persicke M. 2018. Functional characterization of a small alarmone hydrolase in Corynebacterium glutamicum. Front Microbiol 9:916. 10.3389/fmicb.2018.00916. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Yang N, Xie S, Tang N-Y, Choi MY, Wang Y, Watt RM. 2019. The Ps and Qs of alarmone synthesis in Staphylococcus aureus. PLoS One 14:e0213630. 10.1371/journal.pone.0213630. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Jimmy S, Saha CK, Kurata T, Stavropoulos C, Oliveira SRA, Koh A, Cepauskas A, Takada H, Rejman D, Tenson T, Strahl H, Garcia-Pino A, Hauryliuk V, Atkinson GC. 2020. A widespread toxin-antitoxin system exploiting growth control via alarmone signaling. Proc Natl Acad Sci USA 117:10500–10510. 10.1073/pnas.1916617117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Jones GH. 1994. Purification and properties of ATP:GTP 3′-pyrophosphotransferase (guanosine pentaphosphate synthetase) from Streptomyces antibioticus. J Bacteriol 176:1475–1481. 10.1128/jb.176.5.1475-1481.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Jones GH. 1994. Activation of ATP:GTP 3′-pyrophosphotransferase (guanosine pentaphosphate synthetase) in Streptomyces antibioticus. J Bacteriol 176:1482–1487. 10.1128/jb.176.5.1482-1487.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Jones GH, Bibb MJ. 1996. Guanosine pentaphosphate synthetase from Streptomyces antibioticus is also a polynucleotide phosphorylase. J Bacteriol 178:4281–4288. 10.1128/jb.178.14.4281-4288.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Jones GH. 2018. Novel aspects of polynucleotide phosphorylase function in Streptomyces. Antibiotics 7:25. 10.3390/antibiotics7010025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Schofield WB, Zimmermann-Kogadeeva M, Zimmermann M, Barry NA, Goodman AL. 2018. The stringent response determines the ability of a commensal bacterium to survive starvation and to persist in the gut. Cell Host Microbe 24:120–132.e6. 10.1016/j.chom.2018.06.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Cashel M, Gallant J. 1969. Two compounds implicated in the function of the RC gene of Escherichia coli. Nature 221:838–841. 10.1038/221838a0. [DOI] [PubMed] [Google Scholar]
- 46.Primm TP, Andersen SJ, Mizrahi V, Avarbock D, Rubin H, Barry CE. 2000. The stringent response of Mycobacterium tuberculosis is required for long-term survival. J Bacteriol 182:4889–4898. 10.1128/JB.182.17.4889-4898.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Eymann C, Homuth G, Scharf C, Hecker M. 2002. Bacillus subtilis functional genomics: global characterization of the stringent response by proteome and transcriptome analysis. J Bacteriol 184:2500–2520. 10.1128/JB.184.9.2500-2520.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Potrykus K, Murphy H, Philippe N, Cashel M. 2011. ppGpp is the major source of growth rate control in E. coli. Environ Microbiol 13:563–575. 10.1111/j.1462-2920.2010.02357.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Weiss LA, Stallings CL. 2013. Essential roles for Mycobacterium tuberculosis Rel beyond the production of (p)ppGpp. J Bacteriol 195:5629–5638. 10.1128/JB.00759-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Pulschen AA, Sastre DE, Machinandiarena F, Asis AC, Albanesi D, de Mendoza D, Gueiros‐Filho FJ. 2017. The stringent response plays a key role in Bacillus subtilis survival of fatty acid starvation. Mol Microbiol 103:698–712. 10.1111/mmi.13582. [DOI] [PubMed] [Google Scholar]
- 51.Murch AL, Skipp PJ, Roach PL, Oyston PCF. 2017. Whole genome transcriptomics reveals global effects including up-regulation of Francisella pathogenicity island gene expression during active stringent response in the highly virulent Francisella tularensis subsp. tularensis SCHU S4. Microbiology 163:1664–1679. 10.1099/mic.0.000550. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Schäfer H, Beckert B, Frese CK, Steinchen W, Nuss AM, Beckstette M, Hantke I, Driller K, Sudzinová P, Krásný L, Kaever V, Dersch P, Bange G, Wilson DN, Turgay K. 2020. The alarmones (p)ppGpp are part of the heat shock response of Bacillus subtilis. PLoS Genet 16:e1008275. 10.1371/journal.pgen.1008275. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Stallings CL, Stephanou NC, Chu L, Hochschild A, Nickels BE, Glickman MS. 2009. CarD is an essential regulator of rRNA transcription required for Mycobacterium tuberculosis persistence. Cell 138:146–159. 10.1016/j.cell.2009.04.041. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Klinkenberg LG, Lee J, Bishai WR, Karakousis PC. 2010. The stringent response is required for full virulence of Mycobacterium tuberculosis in guinea pigs. J Infect Dis 202:1397–1404. 10.1086/656524. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Prusa J, Zhu DX, Stallings CL. 2018. The stringent response and Mycobacterium tuberculosis pathogenesis. Pathog Dis 76:fty054. 10.1093/femspd/fty054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Njire M, Wang N, Wang B, Tan Y, Cai X, Liu Y, Mugweru J, Guo J, Hameed HMA, Tan S, Liu J, Yew WW, Nuermberger E, Lamichhane G, Liu J, Zhang T. 2017. Pyrazinoic acid inhibits a bifunctional enzyme in Mycobacterium tuberculosis. Antimicrob Agents Chemother 61:e00070-17. 10.1128/AAC.00070-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Dahl JL, Arora K, Boshoff HI, Whiteford DC, Pacheco SA, Walsh OJ, Lau-Bonilla D, Davis WB, Garza AG. 2005. The relA homolog of Mycobacterium smegmatis affects cell appearance, viability, and gene expression. J Bacteriol 187:2439–2447. 10.1128/JB.187.7.2439-2447.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Jain V, Saleem-Batcha R, China A, Chatterji D. 2006. Molecular dissection of the mycobacterial stringent response protein Rel. Protein Sci 15:1449–1464. 10.1110/ps.062117006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Murdeshwar MS, Chatterji D. 2012. MS_RHII-RSD, a dual-function RNase HII-(p)ppGpp synthetase from Mycobacterium smegmatis. J Bacteriol 194:4003–4014. 10.1128/JB.00258-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Ojha AK, Mukherjee TK, Chatterji D. 2000. High intracellular level of guanosine tetraphosphate in Mycobacterium smegmatis changes the morphology of the bacterium. Infect Immun 68:4084–4091. 10.1128/IAI.68.7.4084-4091.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Gupta KR, Kasetty S, Chatterji D. 2015. Novel functions of (p)ppGpp and cyclic di-GMP in mycobacterial physiology revealed by phenotype microarray analysis of wild-type and isogenic strains of Mycobacterium smegmatis. Appl Environ Microbiol 81:2571–2578. 10.1128/AEM.03999-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Petchiappan A, Naik SY, Chatterji D. 2019. RelZ-mediated stress response in Mycobacterium smegmatis: pGpp synthesis and its regulation. J Bacteriol 202:e00444-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Sugisaki K, Hanawa T, Yonezawa H, Osaki T, Fukutomi T, Kawakami H, Yamamoto T, Kamiya S. 2013. Role of (p)ppGpp in biofilm formation and expression of filamentous structures in Bordetella pertussis. Microbiology 159:1379–1389. 10.1099/mic.0.066597-0. [DOI] [PubMed] [Google Scholar]
- 64.Oh YT, Lee K-M, Bari W, Raskin DM, Yoon SS. 2015. (p)ppGpp, a small nucleotide regulator, directs the metabolic fate of glucose in Vibrio cholerae. J Biol Chem 290:13178–13190. 10.1074/jbc.M115.640466. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Kim J-S, Liu L, Fitzsimmons LF, Wang Y, Crawford MA, Mastrogiovanni M, Trujillo M, Till JKA, Radi R, Dai S, Vázquez-Torres A. 2018. DksA-DnaJ redox interactions provide a signal for the activation of bacterial RNA polymerase. Proc Natl Acad Sci USA 115:E11780–E11789. 10.1073/pnas.1813572115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Gaca AO, Kajfasz JK, Miller JH, Liu K, Wang JD, Abranches J, Lemos JA. 2013. Basal levels of (p)ppGpp in Enterococcus faecalis: the magic beyond the stringent response. mBio 4:e00646-13. 10.1128/mBio.00646-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Novosad SA, Beekmann SE, Polgreen PM, Mackey K, Winthrop KL, M. abscessus Study Team . 2016. Treatment of Mycobacterium abscessus infection. Emerg Infect Dis 22:511–514. 10.3201/eid2203.150828. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Cabral DJ, Wurster JI, Belenky P. 2018. Antibiotic persistence as a metabolic adaptation: stress, metabolism, the host, and new directions. Pharmaceuticals 11:14. 10.3390/ph11010014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Fenn K, Wong CT, Darbari VC. 2019. Mycobacterium tuberculosis uses Mce proteins to interfere with host cell signaling. Front Mol Biosci 6:149. 10.3389/fmolb.2019.00149. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Hurst-Hess K, Rudra P, Ghosh P. 2017. Mycobacterium abscessus WhiB7 regulates a species-specific repertoire of genes to confer extreme antibiotic resistance. Antimicrob Agents Chemother 61:e01347-17. 10.1128/AAC.01347-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Brockmann-Gretza O, Kalinowski J. 2006. Global gene expression during stringent response in Corynebacterium glutamicum in presence and absence of the rel gene encoding (p)ppGpp synthase. BMC Genomics 7:230. 10.1186/1471-2164-7-230. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Vercruysse M, Fauvart M, Jans A, Beullens S, Braeken K, Cloots L, Engelen K, Marchal K, Michiels J. 2011. Stress response regulators identified through genome-wide transcriptome analysis of the (p)ppGpp-dependent response in Rhizobium etli. Genome Biol 12:R17. 10.1186/gb-2011-12-2-r17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Yang H, Yu M, Lee JH, Chatnaparat T, Zhao Y. 2020. The stringent response regulator (p) ppGpp mediates virulence gene expression and survival in Erwinia amylovora. BMC Genomics 21:261. 10.1186/s12864-020-6699-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Traxler MF, Zacharia VM, Marquardt S, Summers SM, Nguyen H-T, Stark SE, Conway T. 2011. Discretely calibrated regulatory loops controlled by ppGpp partition gene induction across the ‘feast to famine’ gradient in Escherichia coli: architecture of the stringent response. Mol Microbiol 79:830–845. 10.1111/j.1365-2958.2010.07498.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Ross W, Vrentas CE, Sanchez-Vazquez P, Gaal T, Gourse RL. 2013. The magic spot: a ppGpp binding site on E. coli RNA polymerase responsible for regulation of transcription initiation. Mol Cell 50:420–429. 10.1016/j.molcel.2013.03.021. 10.1016/j.molcel.2013.03.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Jayasingam S, Zin T, Ngeow Y. 2017. Antibiotic resistance in Mycobacterium abscessus and Mycobacterium fortuitum isolates from Malaysian patients. Int J Mycobacteriol 6:387–390. 10.4103/ijmy.ijmy_152_17. [DOI] [PubMed] [Google Scholar]
- 77.Luthra S, Rominski A, Sander P. 2018. The role of antibiotic-target-modifying and antibiotic-modifying enzymes in Mycobacterium abscessus drug resistance. Front Microbiol 9:2179. 10.3389/fmicb.2018.02179. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Bar-On O, Mussaffi H, Mei-Zahav M, Prais D, Steuer G, Stafler P, Hananya S, Blau H. 2015. Increasing nontuberculous mycobacteria infection in cystic fibrosis. J Cystic Fibrosis 14:53–62. 10.1016/j.jcf.2014.05.008. [DOI] [PubMed] [Google Scholar]
- 79.Koskiniemi S, Pränting M, Gullberg E, Näsvall J, Andersson DI. 2011. Activation of cryptic aminoglycoside resistance in Salmonella enterica: activation of cryptic resistance. Mol Microbiol 80:1464–1478. 10.1111/j.1365-2958.2011.07657.x. [DOI] [PubMed] [Google Scholar]
- 80.Aedo S, Tomasz A. 2016. Role of the stringent stress response in the antibiotic resistance phenotype of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 60:2311–2317. 10.1128/AAC.02697-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.van Kessel JC, Hatfull GF. 2007. Recombineering in Mycobacterium tuberculosis. Nat Methods 4:147–152. 10.1038/nmeth996. [DOI] [PubMed] [Google Scholar]
- 82.Kieser KJ, Boutte CC, Kester JC, Baer CE, Barczak AK, Meniche X, Chao MC, Rego EH, Sassetti CM, Fortune SM, Rubin EJ. 2015. Phosphorylation of the peptidoglycan synthase PonA1 governs the rate of polar elongation in mycobacteria. PLoS Pathog 11:e1005010. 10.1371/journal.ppat.1005010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Hartmans S, de Bont JAM, Stackebrandt E. 2006. The genus Mycobacterium – nonmedical, p 889–918. In Dworkin M, Falkow S, Rosenberg E, Schleifer K-H, Stackebrandt E (ed), The prokaryotes. Springer, New York, NY. [Google Scholar]
- 84.Shell SS, Prestwich EG, Baek S-H, Shah RR, Sassetti CM, Dedon PC, Fortune SM. 2013. DNA methylation impacts gene expression and ensures hypoxic survival of Mycobacterium tuberculosis. PLoS Pathog 9:e1003419. 10.1371/journal.ppat.1003419. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods 25:402–408. 10.1006/meth.2001.1262. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Set S1. Download jb.00434-21-s0001.xlsx, XLSX file, 0.6 MB (609.9KB, xlsx)
Tables S1 to S5 and Fig. S1 and S2. Download jb.00434-21-s0002.pdf, PDF file, 0.5 MB (483KB, pdf)

